A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...
Trusted as the #1 ranked genomic testing brand among pediatric and genetic providers For more than 25 years, genetics experts have relied on Infinity as the gold-standard for rare disease insights due ...
Editor’s note: On June 3, 2025, KJ Muldoon was discharged from the hospital and is now at home with his family. When a baby born in Philadelphia was announced as the first person to get a gene therapy ...
Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...
PCR-based techniques have transformed how scientists analyze transcripts’ translational applications in cancer and neuroscience research.
Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...
Venture capital investment in gene therapies fell to $1.4 billion in 2024 from 2021 peak of $8.2 billion Total global biopharma venture funding rose to $27 billion in 2024 from $23.2 billion in 2023 ...
Today, the Nature Health journal has published Monash University’s DNA Screen study results. The study piloted the idea of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback